Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,888 | 136 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sun Pharmaceutical Industries Inc. | $516.86 | 27 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $429.53 | 28 | $0 (2023) |
| Oyster Point Pharma, Inc. | $410.58 | 14 | $0 (2023) |
| Shire North American Group Inc | $355.81 | 9 | $0 (2019) |
| Allergan, Inc. | $233.26 | 15 | $0 (2021) |
| Bausch & Lomb Americas Inc. | $176.34 | 10 | $0 (2024) |
| Alcon Vision LLC | $172.29 | 6 | $0 (2024) |
| AbbVie Inc. | $111.62 | 4 | $0 (2023) |
| Mallinckrodt Enterprises LLC | $68.77 | 4 | $0 (2019) |
| Tarsus Pharmaceuticals, Inc. | $55.49 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $329.39 | 16 | Bausch & Lomb Americas Inc. ($72.31) |
| 2023 | $704.91 | 31 | Oyster Point Pharma, Inc. ($271.88) |
| 2022 | $373.34 | 20 | Oyster Point Pharma, Inc. ($138.70) |
| 2021 | $625.27 | 35 | SUN PHARMACEUTICAL INDUSTRIES INC. ($183.86) |
| 2020 | $217.24 | 11 | Sun Pharmaceutical Industries Inc. ($76.25) |
| 2019 | $430.25 | 15 | Shire North American Group Inc ($198.60) |
| 2018 | $207.97 | 8 | Shire North American Group Inc ($157.21) |
All Payment Transactions
136 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/05/2024 | Alcon Vision LLC | Simbrinza (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: Ophthalmology | ||||||
| 10/25/2024 | Alcon Vision LLC | Simbrinza (Drug) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: Ophthalmology | ||||||
| 10/02/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $24.03 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/20/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 08/05/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: Ophthalmology | ||||||
| 06/17/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $23.31 | General |
| Category: Ophthalmology | ||||||
| 06/17/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: OPTOMETRY | ||||||
| 06/14/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: Ophthalmology | ||||||
| 05/04/2024 | Thea Pharma Inc. | IYUZEH (Drug) | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/30/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: Ophthalmology | ||||||
| 04/29/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: OPTOMETRY | ||||||
| 04/17/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $26.67 | General |
| Category: SOLUTION/ DROPS | ||||||
| 03/18/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $27.34 | General |
| Category: SOLUTION/ DROPS | ||||||
| 03/05/2024 | Johnson & Johnson Surgical Vision, Inc. | Tecnis Simplicity (Device), CATALYS SYSTEM, Tecnis IOL | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: Optics | ||||||
| 03/04/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $31.82 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 01/18/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/30/2023 | Bausch & Lomb Americas Inc. | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: Ophthalmology | ||||||
| 11/21/2023 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: Ophthalmology | ||||||
| 11/21/2023 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: Ophthalmology | ||||||
| 11/18/2023 | AbbVie Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $28.38 | General |
| Category: EYE CARE | ||||||
| 11/09/2023 | AbbVie Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $33.12 | General |
| Category: EYE CARE | ||||||
| 11/02/2023 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | In-kind items and services | $29.25 | General |
| Category: Ophthalmology | ||||||
| 10/04/2023 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | In-kind items and services | $25.21 | General |
| Category: Ophthalmology | ||||||
| 10/03/2023 | AbbVie Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $33.33 | General |
| Category: EYE CARE | ||||||
| 09/07/2023 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | In-kind items and services | $25.25 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 360 | 388 | $62,760 | $23,247 |
| 2022 | 11 | 474 | 512 | $47,975 | $29,298 |
| 2021 | 10 | 427 | 452 | $47,013 | $30,596 |
| 2020 | 8 | 403 | 415 | $38,624 | $25,677 |
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 65 | 65 | $13,000 | $6,376 | 49.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 41 | 56 | $9,725 | $4,308 | 44.3% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 36 | 36 | $8,640 | $3,656 | 42.3% |
| 92250 | Photography of the retina | Office | 2023 | 114 | 117 | $15,210 | $3,518 | 23.1% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 36 | 41 | $5,535 | $2,238 | 40.4% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 28 | 30 | $4,200 | $1,788 | 42.6% |
| 92133 | Imaging of optic nerve | Office | 2023 | 28 | 31 | $4,650 | $943.21 | 20.3% |
| 92134 | Imaging of retina | Office | 2023 | 12 | 12 | $1,800 | $419.83 | 23.3% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 67 | 70 | $10,769 | $6,916 | 64.2% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 69 | 84 | $9,360 | $6,309 | 67.4% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 50 | 50 | $9,092 | $4,872 | 53.6% |
| 92250 | Photography of the retina | Office | 2022 | 112 | 115 | $5,928 | $3,417 | 57.6% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 39 | 47 | $3,810 | $2,526 | 66.3% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2022 | 32 | 32 | $2,432 | $1,408 | 57.9% |
| 92133 | Imaging of optic nerve | Office | 2022 | 37 | 41 | $1,959 | $1,227 | 62.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 16 | 17 | $1,895 | $1,146 | 60.5% |
| 92134 | Imaging of retina | Office | 2022 | 29 | 33 | $2,070 | $1,081 | 52.2% |
| 92020 | Exam of the internal drainage system of eye | Office | 2022 | 11 | 11 | $377.60 | $265.13 | 70.2% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2022 | 12 | 12 | $284.15 | $131.24 | 46.2% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 66 | 66 | $10,595 | $6,620 | 62.5% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2021 | 51 | 51 | $9,712 | $5,989 | 61.7% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 59 | 73 | $8,406 | $5,570 | 66.3% |
| 92250 | Photography of the retina | Office | 2021 | 104 | 106 | $5,770 | $3,795 | 65.8% |
| 68761 | Closure of tear duct opening using plug | Office | 2021 | 11 | 13 | $3,231 | $2,549 | 78.9% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 39 | 42 | $3,639 | $2,548 | 70.0% |
About Dr. Raul Daniels, OD
Dr. Raul Daniels, OD is a Optometrist healthcare provider based in Richmond Hill, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/23/2017. The National Provider Identifier (NPI) number assigned to this provider is 1891215489.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Raul Daniels, OD has received a total of $2,888 in payments from pharmaceutical and medical device companies, with $329.39 received in 2024. These payments were reported across 136 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($2,888).
As a Medicare-enrolled provider, Daniels has provided services to 1,664 Medicare beneficiaries, totaling 1,767 services with total Medicare billing of $108,817. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Practice Information
- Specialty Optometrist
- Location Richmond Hill, NY
- Active Since 06/23/2017
- Last Updated 02/22/2020
- Taxonomy Code 152W00000X
- Entity Type Individual
- NPI Number 1891215489
Products in Payments
- XIIDRA (Drug) $867.41
- Cequa (Drug) $422.86
- TYRVAYA (Drug) $410.58
- RESTASIS MULTIDOSE (Drug) $118.50
- LUMIGAN (Drug) $106.19
- RESTASIS (Drug) $87.07
- PanOptix (Device) $74.18
- VYZULTA (Drug) $73.81
- ACTHAR (Biological) $68.77
- Simbrinza (Drug) $65.87
- BROMSITE (Drug) $56.46
- XDEMVY (Drug) $55.49
- OXERVATE (Drug) $54.01
- Tecnis IOL (Device) $37.50
- VEVYE (Drug) $33.21
- OZURDEX (Drug) $33.12
- LOTEMAX SM (Drug) $32.50
- AcrySof IQ VIVITY IOL (Device) $32.24
- Flarex (Drug) $29.23
- INVELTYS (Drug) $25.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Optometrist Doctors in Richmond Hill
Kevin Singh, Od, OD
Optometrist — Payments: $1,939
Michael Ferri, O.d, O.D
Optometrist — Payments: $1,030
Dr. Miriam Lee, O.d, O.D
Optometrist — Payments: $889.73
Sergio Cisneros, Od, OD
Optometrist — Payments: $874.25
Dr. Veranika Sherman, O.d, O.D
Optometrist — Payments: $540.01
Dr. Roman Kakzanov, Od, OD
Optometrist — Payments: $371.59